National Comprehensive Cancer Network
Follow us on:
- NCCN
Guidelines®- End User License Agreement
- NCCN Guidelines for
Treatment of Cancer by Site- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Anal Carcinoma
- Basal and Squamous Cell Skin Cancers
- Bladder Cancer
- Bone Cancer
- Breast Cancer
- Central Nervous System Cancers
- Cervical Cancer
- Chronic Myelogenous Leukemia
- Colon Cancer
- Dermatofibrosarcoma Protuberans
- Esophageal and Esophagogastric Junction Cancers
- Gastric Cancer
- NCCN Guidelines for Detection,
Prevention, & Risk Reduction - NCCN Guidelines for
Supportive Care - NCCN Guidelines for
Age Related Recommendations - NCCN Guidelines for Patients®
- International Adaptations & Translations
- NCCN Pocket Guidelines
- NCCN Disclosure Policies &
Potential Conflicts of Interest - Licensing and Permissions
- Stay up-to-date with
NCCN Flash Updates™ - NCCN Guidelines Apps
- NCCN
Compendia- End User License Agreement
- NCCN Compendium®
- NCCN Biomarkers Compendium™
- Subscribe to the NCCN Compendia
- Licensing and Permissions
- Subscriptions
& Products- NCCN Compendium
- NCCN Biomarkers Compendium
- NCCN Templates
- Combination Subscriptions
- NCCN Flash Updates™
- NCCN Flash Updates™ Coupons
- NCCN Trends™ Surveys & Data
- NCCN Academy Video Modules
- NCCN eBulletin Newsletter
- NCCN Health Information Technology Licensees
- JNCCN — Journal of the National Comprehensive Cancer Network
- Advertising Opportunities
- NCCN Online Catalog
- Clinical & Business
Resources- Members Only
- NCCN Corporate Council
- NCCN Academy
- NCCN Insights: Analytics, Research & Consulting
- NCCN Resource Tool: REMS
- NCCN Collaboration with the National Business Group on Health
- NCCN Virtual Reimbursement Resource Room
- NCCN Health Information Technology Licensees
- NCCN Oncology Policy Program White Papers
- NCCN Oncology Research Program (ORP)
- ORP Recent News
- NCCN ORP Affiliate Research Project
- ORP Scientific Publications
- ORP Investigator Steering Committee
- ORP Testimonials
- Clinical Trials at NCCN Member Institutions
- Find ORP Funded Clinical Trials at NCCN Member Institutions
- NCCN Specialized Imaging Research Consortium™ (SIRC)
- NCCN ORP Disclosure Policy
- NCCN ORP for Industry
- NCCN Informed Consent Language Database
- NCCN Content Policies
- Patient
Resources- NCCN Guidelines for Patients®
- NCCN Website for Patients and
Caregivers - NCCN.com - Find an NCCN Member Institution
- Find an NCCN Cancer Center Near You
- Information on Patient Assistance & Reimbursement Help
- NCCN Virtual Reimbursement Resource Room Guide
- Find Clinical Trials
- NCCN Foundation
- Donate to the NCCN Foundation
NCCN Oncology Research Program (ORP)
NCCN ORP Recent News
NCCN ORP Affiliate Research Project
NCCN ORP Scientific Publications
NCCN ORP for Industry
NCCN ORP Investigator Steering Committee
NCCN ORP Testimonials
NCCN Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
NCCN Informed Consent Language Database
NCCN Specialized Imaging Research Consortium™ (SIRC)
NCCN ORP Disclosure Policy
NCCN Insights: Analytics, Research & Consulting
NCCN Collaboration with the National Business Group on Health
NCCN Research & Business Resources
NCCN Oncology Research Program (ORP) Recent News
The NCCN Oncology Research Program (ORP) facilitates all phases of clinical research by identifying investigators and initiating clinical trials at NCCN Member Institutions. The NCCN ORP draws on the expertise of investigators at 23 of the world’s leading cancer centers and establishes collaborations with pharmaceutical and biotechnology companies in order to advance therapeutic options for patients with cancer. To date, the NCCN ORP has provided almost $30 million in research funding to investigators at NCCN Member Institutions. Click on a press release below to learn more about the NCCN ORP.
- Researchers Receive Grants from NCCN Oncology Research Program Funded through AVEO/Astellas Collaboration (10/15/2012)
- Researchers Receive Grants from NCCN Oncology Research Program Funded Through GlaxoSmithKline (9/6/2012)
For questions about NCCN or for interview information, please contact Jennifer Tredwell 215.690.0274.
NCCN Oncology Research Program (ORP) News Archive
- NCCN Qualifies First Community Sites for Affiliate Research Project (7/10/2012)
- NCCN Collaborates with AVEO and Astellas on Innovative Cancer Research (2/16/2012)
- NCCN Receives $2 Million in Oncology Research Funding from Boehringer Ingelheim to Investigate Afatinib in Solid Tumors (11/10/2011)
- NCCN Receives $4 Million in Oncology Research Funding from GlaxoSmithKline (10/11/2011)
- Researchers Receive Grants from NCCN Oncology Research Program Funded Through GlaxoSmithKline (8/31/2011)
- Researchers Receive Grants from NCCN Oncology Research Program Funded Through Pfizer (7/5/2011)
- NCCN Advances Oncology Imaging Research through the NCCN Specialized Imaging Research Consortium (5/27/2011)
- National Comprehensive Cancer Network and Society of Nuclear Medicine Join to Advance Oncology Imaging Research (3/8/2011)
- NCCN Receives $2.1 Million in Oncology Research Funding from Pfizer (11/30/2010)
- NCCN Receives $4 Million in Oncology Research Funding from GlaxoSmithKline (7/27/2010)
- NCCN Survey Analyzes Clinical Trial Accrual at Academic Cancer Centers (6/4/2010)
- NCCN Receives Research Grant to Evaluate Pralatrexate in Solid Tumors and Hematologic Malignancies (11/10/2009)
- NCCN Holds Oncology Research Best Practices Conference (9/14/2009)
- NCCN Oncology Research Program Celebrates 10th Anniversary by Closing in on $20 Million in Funding; Program Expands into Developmental Therapies (4/29/2009)
- NCCN Receives $4 Million Oncology Research Grant from Wyeth (1/15/2009)
- Combination Cancer Therapy is Focus of $1M Merck Research Grant Received by NCCN (12/1/2008)
- NCCN Receives $1.5 Million Grant to Research Targeted Therapy in Bladder Cancer (11/24/2008)
- NCCN, Abraxis BioScience and AstraZeneca Announce Collaboration to Conduct Anti-Cancer Drug Studies (10/7/2008)
- NCCN Receives Major Grant for Anti-Cancer Drug Study (11/15/2007)
- NCCN Receives $2 Million Grant from Pfizer (9/5/2006)
- NCCN and Roche Collaborate on Innovative Cancer Research (10/31/2005)
- Diane E. Paul, MS, RN, Joins National Comprehensive Cancer Network as Vice President, Clinical Trials Network (6/13/2005)
- Researchers Receive $1,886,237 in Funding from NCCN Clinical Trials Network (2/20/2003)
- The National Comprehensive Cancer Network Provides Physicians Easier Identification of Clinical Trials for Their Patients (11/5/2002)
- The National Comprehensive Cancer Network Launches Clinical Trials Network to Speed Drug Discovery (6/5/2002)
- Pharmacia Gives $3.15 Million Grant to NCCN to Advance Innovative Cancer Research Collaboration (1/1/2002)
| Quick Links |
|
|
About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us
275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0280
Copyright © 2013 National Comprehensive Cancer Network, All Rights Reserved